Related Experiment Videos
Future developments in implantable cardioverter defibrillators: the optimal device
1Clinical Electrophysiology Laboratories, Hospital of the University of Pennsylvania, Philadelphia.
Insights
Sudden cardiac death (SCD) is a major mortality cause, often from ventricular tachyarrhythmias. Implantable cardioverter-defibrillators (ICDs) effectively prevent SCD, with future devices promising further improvements.
Area of Science:
- Cardiology
- Medical Devices
- Sudden Cardiac Death
Background:
- Sudden cardiac death (SCD) remains a leading cause of mortality, primarily due to ventricular tachyarrhythmias in patients with structural heart disease.
- Current primary prevention strategies for SCD have shown limited success, highlighting the need for effective interventions.
Purpose of the Study:
- To review the effectiveness of current treatments for SCD survivors, focusing on implantable cardioverter-defibrillators (ICDs).
- To discuss the future directions and desired characteristics of optimal ICDs for improved patient outcomes and broader application.
Main Methods:
- Review of existing literature on SCD, its causes, and treatment strategies.
- Analysis of the efficacy of antiarrhythmic drugs, endocardial resection, and ICDs in SCD management.
- Discussion of technological advancements and future requirements for ideal ICD systems.
Main Results:
- Implantable cardioverter-defibrillators (ICDs) are highly effective in preventing recurrent sudden cardiac death from ventricular tachyarrhythmias.
- Widespread ICD adoption depends on demonstrating improved total mortality, cost-effectiveness, and device enhancements.
Conclusions:
- Future ICDs should feature non-thoracotomy lead placement, subpectoral generator placement, multiprogrammable tiered therapy, and enhanced diagnostic and data storage capabilities.
- Continued technological innovation is crucial for developing ideal ICDs, offering optimism for reducing SCD mortality.
Abstract:
Despite recent therapeutic advances, SCD remains the leading cause of mortality in industralized nations. The most frequent cause of SCD is ventricular tachyarrhythmias in the setting of advanced structural heart disease due to chronic coronary heart disease or idiopathic dilated cardiomyopathy. Although high-risk groups can be prospectively identified, attempts at primary prevention have been largely unsuccessful. Effective treatment strategies for SCD survivors include antiarrhythmic drug therapy guided by programmed stimulation, endocardial resection, and ICDs. Device therapy has proven extremely effective in preventing recurrent sudden death from ventricular tachyarrhythmias. Widespread application of ICD therapy, perhaps even to include members of high-risk populations that have not experienced cardiac arrest, will depend on many factors including the demonstration that device therapy improves total mortality, not just arrhythmia-related mortality, reduction in cost, and improvements in the devices themselves. Some of the important characteristics of the optimal ICD of the future are nonthoracotomy lead placement; subpectoral generator placement; multiprogrammable, tiered therapy; improved diagnostic specificity, whether based on electrogram or hemodynamic-sensing algorithms; improved integration of brady- and tachy-sensing systems; and enhanced electrogram storage capability with trans-telephonic retrieval of electrogram recordings. The creation of this ideal ICD will obviously require continued technological advances; however, given the tremendous improvements realized over the first three generations of ICD systems, optimism for the future seems warranted.